The Mining Of Nigerian Medicinal Plants For Cancer Therapy

Isa Marte Hussaini(1),

(1) University of Maiduguri, The Nigerian Academy of Science
Corresponding Author


Tumour is an abnormal growth of cells which form a mass called neoplasm. When the tumor is slow growing and confined to a certain organ it is called benign. Sometimes the tumour can progress into a malignant phenotype while in some situations the cancer cells break away from a tumour mass and spread to other tissues or organs such as the brain and bones through the blood or lymph system. The tumour cells can settle in new places and form new masses. When this happens, the process is called metastasis. This type of neoplasm is called cancer. However certain tumours such as astrocytomas (brain tumors) even when malignant hardly metastasize outside the brain. In contrast breast, prostate and other cancers can metastasize to the brain.

Cancer occurs when cells in a part of the body begin to grow out of control. Normal cells divide and grow in an orderly fashion, but cancer cells do not. They continue to grow and crowd out normal cells. Although there are many kinds of cancers, they all have, in common, this out-of-control growth of cells. Other hallmarks of cancers include; sustained angiogenesis (increased blood vessel supply), high invasive and migratory rates, ability to overcome programmed cell death (apoptosis), limitless proliferative potential, insensitivity to anti-growth signals and self-sufficiency in growth signals (Hanahan and Weinberg, 2000). Different kinds of cancers do not behave in the same manner. For example, lung and breast cancers are very different diseases. Cancers grow at different rates and respond to different treatments. As a result of the heterogeneity of cancers, treatment strategies should be tailored to be patient and cancer-specific.


Cancer, Medicinal Plants, Cancer Therapy


Abubakar, MS, M USA, A .M, Ahmed A. and Hussaini, IM (2007) The perception and practice of traditional medicine in the treatment of cancers and inflammations by the Hausa and Fulani tribes of Northern Nigeria. J of Ethnopharmacology 111: 625–629.

Mohammed SD, Abubakar, MS and Hussaini, IM (2007; Unpublished data) Cancer Cases in ABUTH 2005 -2007.

Deininger M and Druker BJ. (2003) Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib, Pharmacol Rev. 55:401423.

Hanahan D and Weinberg RA (2000) The Hallmarks of Cancer, Cell 100 (1):57-

Herbst RS (2004) “Review of Epidermal Growth Factor Receptor Biology” Int. J. Radiation Oncol. Biol. Phys 59:21-26.

Hussaini IM ( scholar).

Isakoff SJ and Baselga J (2011) Trastuzum ab-DM1: Building a ChemotherapyFree Road in the Treatment of Human Epidermal Growth Factor Receptor 2 –P ositive Breast Cancer. J. Clinoncology 4: 351-354

Iwu, M. M., (1994) African Medicinal Plants in the Search for New Drugs Based on Ethnobotanical Leads. Ethnobotany and Search for New Drugs. Wiley, Chichester, pp. 116 –129.

Kuan, CT, Wikstrand CT, Bigner DD “EGF mutant receptor vIII as a molecular target in cancer therapy” Endocr. Relat. Cancer 8:83-96.

Full Text: PDF

Article Metrics

Abstract View : 185 times
PDF Download : 33 times

DOI: 10.57046/ZNWB3670


  • There are currently no refbacks.

Copyright (c) 2019 Proceedings of the Nigerian Academy of Science